ALLSKIN | MED Pigment Control Plan with FREE Heliocare 360° Sunscreen

Reduce your patients risk of hyperpigmentation this summer with the ALLSKIN | MED Pigment Control Plan
Get the ALLSKIN | MED Pigment Control Plan with the Heliocare 360° SPF 50+ Pigment Solution Fluid Sunscreen FREE, and help your patients control the risk of hyperpigmentation this summer for only £130 SRP incl. VAT
Promote this offer directly to your patients: “Reduce your risk of hyperpigmentation this summer with the ALLSKIN | MED Pigment Control Plan. Purchase the ALLSKIN | MED Pigment Control Plan for £130 with Heliocare 360° Pigment Solution Fluid Sunscreen FREE (worth SRP £32.99)”
20% discount on normal professional prices

Existing customers can buy the product now via the Professional Shop. Otherwise, you can enquire about this product and learn how to stock it.

About ALLSKIN | MED Pigment Control Plan with FREE Heliocare 360° Sunscreen

Reduce your patients risk of hyperpigmentation this summer with the ALLSKIN | MED Pigment Control Plan.

Get the ALLSKIN | MED Pigment Control Plan with the Heliocare 360° SPF 50+ Sunscreen Pigment Solution Fluid FREE and help your patients control the risk of hyperpigmentation this summer.

The ALLSKIN | MED Pigment Control Plan is a three-step approach to correct and prevent hyperpigmentation, providing a daily medical grade skincare regime clinically proven to significantly reduce the severity and area of hyperpigmentation.^1,2,3,4 Exclusively available from aesthetic skin clinics the plan contains:

Heliocare 360° SPF50+ Sunscreen Pigment Solution Fluid
ALLSKIN | MED Pigment Control Serum
ALLSKIN | MED Pigmentation Oral Capsules

Key Ingredients

Pigment Control Capsules:

Photoprotective and anti-ageing: Fernblock®

Antioxidants: Fernblock®, Vitamin C & Pomegranate Extract

Depigmenting: Niacinamide and Cystine

Pigment Control Serum:

Cellular renewal: Retinoids

Pigmentation suppressors: Kojic acid and N-Acetylglucosamine

Skin brightener: Niacinamide

Exfoliator: Salicylic acid

Skin hydrators

Heliocare 360° Pigment Solution Fluid:

High-level protection: SPF50+ and PA++++ provide advanced, full-spectrum defence against UVA, UVB, visible light, and infrared-A rays

Innovative ASPA-Fernblock® technology: Clinically proven to enhance the skin’s natural defences against UVA, visible light, infrared-A, and free radicals, while supporting DNA repair

Optimised vitamin D function: OptiD Effect helps maintain the skin’s natural ability to produce and utilise vitamin D

Advanced Depigmenting System: Formulated with Niacinamide to prevent melanin transfer and Ellagic Acid to reduce melanin production, helping to minimise pigmentation concerns

Seamless, skin-perfecting tint: Silky formula with a subtle tint blends effortlessly into the skin, unifying tone and masking pigmentation patches

‘Second Skin’ technology: Locks in moisture while creating a breathable protective barrier against pollution

Enquire About ALLSKIN | MED Pigment Control Plan and the Complete Portfolio

¹ Goh C.L., Chuah, S.Y., Tien, S., Thing, G., Vitali, M.A., Delgardo-Rubin, A. Double-blind, placebo-controlled trial to evaluate the effectiveness of P. leucotomos extract in the treatment of melasma in Asian skin: A pilot study. Journal of Clinical and Aesthetic Dermatology. March 2018 • Volume 11 • Number 3
² Martin LK, Caperton C, Woolery-Lloyd H, et al. A randomized double-blind placebo-controlled study evaluating the effectiveness and tolerability of oral Polypodium leucotomos in patients with melasma. American Academy of Dermatology Annual Meeting. San Diego, CA; March 16–20, 2012.
³ Truchuelo MT, Jimenez N, Jaen P. Assesment of the efficacy and tolerance of a new combination of retinoids and depigmenting agents in the treatment of melasma, Journal of Cosmetic Dermatology, 13, 261-268.
⁴ Truchuelo MT, Gabriel MT, Chan HP, Chan GP and Vitale M. Safety and Efficacy of a New Regimen in Homogenizing and Brightening Skin Complexion Among Filipino Women. SM J Dermatolog. 2017; 3(1): 1011.
⁵ Data on file: Dermatologist and volunteer assessment after 90 days of continuous use.